Clinical Trials Directory

Trials / Completed

CompletedNCT00291499

Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand

Clinical Evaluation of Condrosulf 800 mg in the Treatment of Symptomatic OA of the Hand: a 6-month, Double-blind, Placebo Controlled Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
163 (actual)
Sponsor
IBSA Institut Biochimique SA · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The goal of the present study is to investigate the effectiveness of Condrosulf® 800 mg tablets vs. placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis. Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf®, versus placebo.

Detailed description

The goal of the present study is to investigate the effectiveness of Condrosulf® 800 mg tablets vs. placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis in 160 randomised patients. Primary endpoints: Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf®, versus placebo. Secondary endpoints are: Efficacy evaluation: Global impression of efficacy expressed by the patient and the physician (VAS), Grip strength (measured manometrically); Morning stiffness duration; Consumption of Paracetamol; Tolerability (4-point verbal scale); Adverse Events occurring during the treatment period; Other parameters:Treatment compliance; Biological markers of arthritis

Conditions

Interventions

TypeNameDescription
DRUGChondroitin 4&6 sulfate (Condrosulf)800 mg/day for 6 months
OTHERPlacebo800 mg placebo/day for 6 months

Timeline

Start date
2005-06-01
Primary completion
2009-12-01
Completion
2010-08-01
First posted
2006-02-14
Last updated
2021-03-04
Results posted
2021-03-04

Source: ClinicalTrials.gov record NCT00291499. Inclusion in this directory is not an endorsement.